Markets:

Overview

News

Currencies

International

Treasuries

Sarepta Therapeutics, Inc. - Common Stock (NQ:SRPT)

17.01 +0.36 (+2.16%)

Streaming Delayed Price Updated: 10:22 AM EDT, Mar 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sarepta Therapeutics, Inc. - Common Stock

< Previous 1 2

...

28 29 30 31 32 33 34 35 Next >

Mainz Biomed (MYNZ) nominates two notable leaders in key areas of the diagnostics field to its Board of Directors

September 29, 2022

Via AB Newswire

A Trio of Q3 Winners With Room to Run

September 29, 2022

It's those rare bright spots in a dim market that can be the best places to hide. Here are three Q3 outperformers that still have good upside.

Via MarketBeat

Topics Economy Stocks

PepGen's Duchenne Candidate Has Potential For Greater Exon Skipping Capabilities At Lower Doses Versus Sarepta's Candidate, Says Analyst ↗

September 28, 2022

Via Benzinga

$6 Million Bet On Sarepta Therapeutics? 3 Stocks Insiders Are Buying ↗

September 16, 2022

Although US stocks closed lower on Thursday, there were a few notable insider trades.

Via Benzinga

Analyst Ratings for Sarepta Therapeutics ↗

September 08, 2022

Within the last quarter, Sarepta Therapeutics (NASDAQ:SRPT) has observed the following analyst ratings:

Via Benzinga

FDA Lifts Clinical Hold On Sarepta's Dose-Expansion Part Of Duchenne Trial ↗

September 06, 2022

Via Benzinga

Sarepta In-Licenses Next-Gen AAV Tech Covering Five Indications ↗

August 08, 2022

Via Benzinga

Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin ↗

September 15, 2022

The market is struggling, yet biotech stocks are acting like it's good times again. Here's why.

Via Investor's Business Daily

A Biotech's Stock Just Hit Year High. This Analyst Expects It To Jump Another 16% ↗

September 08, 2022

Morgan Stanley raised the price target on Sarepta Therapeutics Inc (NASDAQ: SRPT) with an equal weight rating.

Via Benzinga

15 Biotech Stocks That Hit Year Highs Over The Last Week, Including Sarepta, Axsome ↗

August 30, 2022

Not all shares are slowing down alongside the industry group.

Via Investor's Business Daily

Is Biotech Back? This Analyst Sees 18% Upside Potential In This Bio Play ↗

August 08, 2022

Sarepta Therapeutics Inc. (NASDAQ: SRPT), a pioneer in precision genetic medicine for rare diseases, announced Monday that it had signed licensing agreements with the Broad Institutes of both MIT and...

Via Benzinga

Sarepta's Duchenne Gene Therapy Update Gets Bullish Stance From Analysts ↗

August 03, 2022

Via Benzinga

Duchenne Gene Therapy Firm Sarepta Therapeutics' Earns 8% Price Target Hike From This Analyst ↗

July 29, 2022

Via Benzinga

Sarepta (SRPT) Stock Gains on FDA News ↗

July 29, 2022

Sarepta Therapeutics (SRPT) stock is rising higher on Friday thanks to an update concerning its Duchenne muscular dystrophy treatment.

Via InvestorPlace

Sarepta Therapeutics: Q2 Earnings Insights ↗

August 02, 2022

Sarepta Therapeutics (NASDAQ:SRPT) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Sarepta Therapeutics...

Via Benzinga

Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study ↗

August 02, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Sarepta Therapeutics Earnings Preview ↗

August 01, 2022

Sarepta Therapeutics (NASDAQ:SRPT) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that Sarepta...

Via Benzinga

Chevron, Amazon And Some Other Big Gainers From Friday ↗

August 01, 2022

U.S. stocks closed higher on Friday, with the Dow Jones jumping more than 300 points. Here is the list of some big stocks moving higher in the previous session.

Via Benzinga

Earnings Scheduled For August 2, 2022 ↗

August 02, 2022

Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.

Via Benzinga

Recap Of Friday's Biotech Catalysts - End of The Day Summary ↗

July 29, 2022

Via Benzinga

Where Sarepta Therapeutics Stands With Analysts ↗

July 29, 2022

Over the past 3 months, 6 analysts have published their opinion on Sarepta Therapeutics (NASDAQ:SRPT) stock. These analysts are typically employed by large Wall Street banks and tasked with...

Via Benzinga

Apple, Amazon And Some Other Big Stocks Recording Gains On Friday ↗

July 29, 2022

Getty Images Holdings, Inc. (NYSE: GETY) shares jumped 106.7% to $21.69 after nearly 99.4% of shares were redeemed by CCNB shareholders.

Via Benzinga

Exxon Mobil (XOM) Stock Pops on Record Profits ↗

July 29, 2022

Exxon Mobil (XOM) stock is rising on Friday following the release of its earnings report for the second quarter of the year.

Via InvestorPlace

CENN Stock Alert: Cenntro Invests in E-Cargo Designer ↗

July 29, 2022

Cenntro (CENN) stock is on the move Friday as investors react to news of the electric vehicle (EV) company acquiring a stake in Antric.

Via InvestorPlace

Sarepta Intents To Seek Accelerated Approval For Gene Therapy Candidate ↗

July 29, 2022

Sarepta Therapeutics (NASDAQ: SRPT) announced its intention to submit Biologics License Application (BLA) seeking accelerated approval for SRP-9001 to treat ambulant individuals with Duchenne muscular...

Via Benzinga

Daily Biotech Pulse: Bausch Health To Appeal Xifaxan Patent Decision, Bristol Myers Drug Combo Fails In Kidney Cancer Trial, Sarepta's Duchenne Candidate Update ↗

July 29, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

July 20, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Avidity Biosciences Or Dyne Therapeutics - Read On Raymond James' Rating Skew ↗

July 12, 2022

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

July 07, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Investors Search for Clues in Economic Data, Recession Signals ↗

July 06, 2022

Stocks are extending this morning's quiet losses, as investors continue to keep an eye on signs of an oncoming recession.

Via Talk Markets

< Previous 1 2

...

28 29 30 31 32 33 34 35 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.